Patents by Inventor Chi-Chuan Tseng

Chi-Chuan Tseng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Specific antagonists for glucose-depenent insulinotropic polypeptide (GIP)
    Publication number: 20080182795
    Abstract: In one embodiment, this invention provides an antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting essentially of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP. In another embodiment, this invention provides a method of treating non-insulin dependent diabetes mellitus in a patient comprising administering to the patient an antagonist of glucose-dependent insulinotropic polypeptide (GIP). In yet another embodiment, this invention provides a method of improving glucose tolerance in a mammal comprising administering to the mammal an antagonist of glucose-dependent insulinotropic polypeptide (GIP).
    Type: Application
    Filed: March 4, 2008
    Publication date: July 31, 2008
    Applicant: Boston Medical Center
    Inventors: M. Michael Wolfe, Chi-Chuan Tseng, Linda Neville
  • Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)
    Publication number: 20080125371
    Abstract: In one embodiment, this invention provides an antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting essentially of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP. In another embodiment, this invention provides a method of preventing and treating obesity and non-insulin dependent diabetes mellitus (Type II) in a patient comprising administering to the patient an antagonist of glucose-dependent insulinotropic polypeptide (GIP). In yet another embodiment, this invention provides a method of improving glucose tolerance in a mammal comprising administering to the mammal an antagonist of glucose-dependent insulinotropic polypeptide (GIP).
    Type: Application
    Filed: August 15, 2006
    Publication date: May 29, 2008
    Inventors: M. Michael Wolfe, Chi-Chuan Tseng, Linda Neville
  • Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)
    Publication number: 20070173455
    Abstract: In one embodiment, this invention provides an antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting essentially of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP. In another embodiment, this invention provides a method of preventing and treating obesity and non-insulin dependent diabetes mellitus (Type II) in a patient comprising administering to the patient an antagonist of glucose-dependent insulinotropic polypeptide (GIP). In yet another embodiment, this invention provides a method of improving glucose tolerance in a mammal comprising administering to the mammal an antagonist of glucose-dependent insulinotropic polypeptide (GIP).
    Type: Application
    Filed: August 14, 2006
    Publication date: July 26, 2007
    Inventors: M. Wolfe, Chi-Chuan Tseng, Linda Neville
  • Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)
    Publication number: 20070167363
    Abstract: In one embodiment, this invention provides an antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting essentially of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP. In another embodiment, this invention provides a method of preventing and treating obesity and non-insulin dependent diabetes mellitus (Type II) in a patient comprising administering to the patient an antagonist of glucose-dependent insulinotropic polypeptide (GIP). In yet another embodiment, this invention provides a method of improving glucose tolerance in a mammal comprising administering to the mammal an antagonist of glucose-dependent insulinotropic polypeptide (GIP).
    Type: Application
    Filed: August 15, 2006
    Publication date: July 19, 2007
    Inventors: M. Wolfe, Chi-Chuan Tseng, Linda Neville
  • Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)
    Publication number: 20070167374
    Abstract: In one embodiment, this invention provides an antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting essentially of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP. In another embodiment, this invention provides a method of preventing and treating obesity and non-insulin dependent diabetes mellitus (Type II) in a patient comprising administering to the patient an antagonist of glucose-dependent insulinotropic polypeptide (GIP). In yet another embodiment, this invention provides a method of improving glucose tolerance in a mammal comprising administering to the mammal an antagonist of glucose-dependent insulinotropic polypeptide (GIP).
    Type: Application
    Filed: August 15, 2006
    Publication date: July 19, 2007
    Inventors: M. Wolfe, Chi-Chuan Tseng, Linda Neville
  • Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)
    Patent number: 7091183
    Abstract: In one embodiment, this invention provides an antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting essentially of a 24 amino acid polypeptide corresponding to positions 7–30 of the sequence of GIP. In another embodiment, this invention provides a method of preventing and treating obesity and non-insulin dependent diabetes mellitus (Type II) in a patient comprising administering to the patient an antagonist of glucose-dependent insulinotropic polypeptide (GIP). In yet another embodiment, this invention provides a method of improving glucose tolerance in a mammal comprising administering to the mammal an antagonist of glucose-dependent insulinotropic polypeptide (GIP).
    Type: Grant
    Filed: December 3, 1997
    Date of Patent: August 15, 2006
    Assignee: Boston Medical Center Corporation
    Inventors: M. Michael Wolfe, Chi-Chuan Tseng, Linda Neville
  • Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)
    Publication number: 20020151495
    Abstract: In one embodiment, this invention provides an antagonist of glucose-dependent insulinotropic polypeptide (GIP) consisting essentially of a 24 amino acid polypeptide corresponding to positions 7-30 of the sequence of GIP. In another embodiment, this invention provides a method of treating non-insulin dependent diabetes mellitus in a patient comprising administering to the patient an antagonist of glucose-dependent insulinotropic polypeptide (GIP). In yet another embodiment, this invention provides a method of improving glucose tolerance in a mammal comprising administering to the mammal an antagonist of glucose-dependent insulinotropic polypeptide (GIP).
    Type: Application
    Filed: October 23, 2001
    Publication date: October 17, 2002
    Inventors: M. Michael Wolfe, Chi-Chuan Tseng, Linda Neville